Neoadjuvant therapy versus upfront surgery for potentially resectable pancreatic cancer: a markov decision analysis

HIGHLIGHTS

  • who: Alison Bradley and Robert Van Der Meer from the Department of Management Science, Strathclyde Business School, University of Strathclyde, Glasgow, Scotland, United Kingdom have published the research: Neoadjuvant therapy versus upfront surgery for potentially resectable pancreatic cancer: A Markov decision analysis, in the Journal: PLOS ONE | https://doi.org/10.1371/journal.pone [0212805]. February 28, 2019 of /1371/
  • what: In the absence of large randomized controlled trials offering a direct comparison this study aims to use Markov decision analysis to compare efficacy of traditional first (SF) and treatment (NAT) pathways for potentially resectable . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?